Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04463979 · ClinicalTrials.gov registry record
Perioperative Evaluation of Cerebellar Tumors
A clinical trial of Brain Tumor and Cerebellar Tumors, sponsored by Duke University.
- Active
- Registry status
- 66
- Enrollment target
- 1
- Study location
NCT04463979 is a study of Brain Tumor and Cerebellar Tumors that is active but no longer recruiting, run by Duke University. The registered enrollment target is 66 participants, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04463979, a study of Brain Tumor and Cerebellar Tumors, is active but no longer recruiting, sponsored by Duke University.
- ACTIVE NOT RECRUITING
- Registry status
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, cohort study to evaluate the impact of cerebellar functional topography on perioperative outcomes related to cognition and motor ataxia in patients with cerebellar tumors.
Conditions Studied
Interventions
- OTHER Impact of Cerebellar Functional Topography on Cognition and Motor Ataxia
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2021-02-28 |
| Est. Completion | 2027-05-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04463979
The ClinicalTrials.gov registry entry for NCT04463979 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 281-participant average among 69 other Brain Tumor trials with a reported enrollment target (77% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Impact of Cerebellar Functional Topography on Cognition and Motor Ataxia is the first listed.
NCT04463979 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04463979 about?
NCT04463979 is a clinical study titled "Perioperative Evaluation of Cerebellar Tumors". This is a prospective, cohort study to evaluate the impact of cerebellar functional topography on perioperative outcomes related to cognition and motor ataxia in patients with cerebellar tumors.
What is the current status of trial NCT04463979?
This trial is currently active not recruiting. The enrollment target is 66 participants. The study started on 2021-02-28. Estimated completion is 2027-05-17.
What conditions does trial NCT04463979 study?
This clinical trial studies the following conditions: Brain Tumor, Cerebellar Tumors.
What interventions are being tested in trial NCT04463979?
The interventions under investigation include: Impact of Cerebellar Functional Topography on Cognition and Motor Ataxia (OTHER).
Who is sponsoring clinical trial NCT04463979?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04463979 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RECRUITING · Phase 1
-
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
RECRUITING
-
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RECRUITING · Phase 1
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
RECRUITING · Phase 1
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.